Skip to main content
OpenTrials
Completed

NCT Number: NCT07313137

Antiplatelet Use in Dementia Subtypes

This population-based retrospective cohort study aimed to evaluate the appropriateness of antiplatelet therapy use among older adults with all-cause dementia and across different dementia subtypes. Medical records of patients aged 65 years and older who were evaluated at a tertiary-level geriatric outpatient clinic were reviewed. Dementia subtypes were classified according to internationally accepted diagnostic criteria. Patterns of antiplatelet use were assessed in accordance with current guideline recommendations. The study sought to determine the appropriateness of antiplatelet use across dementia subtypes and to describe real-world prescribing practices in this population.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 65 years and older.
  • Diagnosis of dementia based on internationally accepted diagnostic criteria.
  • Evaluation at a tertiary-level geriatric outpatient clinic.

Exclusion criteria

  • Patients with incomplete or inaccessible medical records.
  • Individuals with missing data on antiplatelet therapy use.

Treatment and study plan

Primary outcomes

  1. Appropriateness of antiplatelet therapy use

    Time frame: At baseline (first geriatric outpatient clinic visit)

    Assessment of the appropriateness of antiplatelet therapy use according to current guideline recommendations among older adults with dementia.

Sponsors and collaborators

Lead sponsor

Gulhane Training and Research Hospital

Other Gov

Registry information

Official study title

Antiplatelet Use in All-Cause Dementia and Dementia Subtypes Among Older Adults: A Population-Based Cohort Study

Important dates

Study start
2016
Primary completion
2025
Study completion
2025
First posted
Dec 31, 2025
Registry last updated
Dec 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.